Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - P/B ratio
P/B ratio as of April 2024 : 6.72
According to Y-mAbs Therapeutics
's latest financial reports the company has a price-to-book ratio of 6.72.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Y-mAbs Therapeutics - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.95 | 50.99% |
| 2022-12-31 | 1.95 | -50.33% |
| 2021-12-31 | 3.93 | -79.27% |
| 2020-12-31 | 19.0 | 203.63% |
| 2019-12-31 | 6.24 | 26.12% |
| 2018-12-31 | 4.95 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.48 | -63.15% | 🇺🇸 USA |